Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Subjects With Impaired Renal Function and Healthy Subjects”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT06657560
What this trial is testing

Pharmacokinetics, Dialysability and Safety of HRS-9231 in Healthy Volunteers and in Patients With Impaired Renal Function

Who this might be right for
Contrast-Enhanced Magnetic Resonance Imaging Detection
Shanghai Shengdi Pharmaceutical Co., Ltd 41
Post-approval studies (Phase 4)Study completedNCT01491113
What this trial is testing

Pharmacokinetic (PK) Study in Japanese Non-epileptic Renal Impaired Patients

Who this might be right for
Healthy SubjectsRenal Impairments
UCB Pharma 30
Early research (Phase 1)Study completedNCT05431426
What this trial is testing

PK of CHF6001 in Subjects With Mild, Moderate and Severe Renal Impairment vs. Healthy Volunteers

Who this might be right for
Chronic Obstructive Pulmonary Disease
Chiesi Farmaceutici S.p.A. 44
Early research (Phase 1)Study completedNCT05012436
What this trial is testing

Evaluate the Pharmacokinetics and Safety of YHD1119 in Subjects With Renal Impairment and Healthy Subjects

Who this might be right for
Healthy VolunteerRenal Impairments
Yuhan Corporation 16
Early research (Phase 1)Study completedNCT01569815
What this trial is testing

Pharmacokinetics of LCZ696 in Subjects With Mild and Moderate Renal Impairment Compared to Healthy Subjects With Normal Renal Function

Who this might be right for
Mild and Moderate Renal Impairment
Novartis Pharmaceuticals 32
Early research (Phase 1)Study completedNCT00674856
What this trial is testing

A Pharmacokinetics and Safety Study of Naproxcinod in Subjects With Impaired Renal Function

Who this might be right for
Renal Failure
NicOx 32
Early research (Phase 1)Study completedNCT01975337
What this trial is testing

Pharmacokinetics and Safety of Alisporivir in Subjects With End Stage Renal Disease on Hemodialysis Compared to Healthy Subjects

Who this might be right for
Kidney Failure, Chronic
Debiopharm International SA 16
Early research (Phase 1)Study completedNCT04364464
What this trial is testing

Study on the Safety of BAY 63-2521, How it is Tolerated and the Way the Body Absorbs, Distributes and Gets Rid of the Study Drug Given as a Single Oral Dose of 1 mg Tablet in Participants With Renal Impairment and Healthy Participants Matched for Age-, Gender-, and Weight

Who this might be right for
Clinical Pharmacology
Bayer 40
Early research (Phase 1)Study completedNCT00715702
What this trial is testing

Safety Study of AZD5672 in Renally Impaired Subjects

Who this might be right for
Renal Impairment
AstraZeneca 40
Early research (Phase 1)Study completedNCT01825889
What this trial is testing

Evacetrapib (LY2484595) in Participants With Severe Renal Impairment and in Healthy Participants

Who this might be right for
Cardiovascular Disease
Eli Lilly and Company 20
Early research (Phase 1)Study completedNCT02048787
What this trial is testing

Pharmacokinetic Study of Buparlisib in Subjects With Renal Impairment.

Who this might be right for
Renal Impairment
Novartis Pharmaceuticals 19
Early research (Phase 1)Study completedNCT01442259
What this trial is testing

An Open-label, Parallel-group Study to Determine the Pharmacokinetics of a Single Dose of AFQ056 in Subjects With Renal Impairment Compared to Healthy Subjects

Who this might be right for
Mild Moderateor Severe Renal Impairment
Novartis Pharmaceuticals 48
Early research (Phase 1)Study completedNCT03442725
What this trial is testing

Study to Compare a Dose of Telotristat Etiprate in Subjects With Renal Impairment With Matched Subjects With Normal Renal Function

Who this might be right for
Renal Impairment
Ipsen 16
Early research (Phase 1)Ended earlyNCT00984113
What this trial is testing

Pharmacokinetics of Elinogrel in Healthy Volunteers and Patients With Mild, Moderate, and Severe Renal Impairment

Who this might be right for
Renal Impairment
Portola Pharmaceuticals 44
Testing effectiveness (Phase 2)Study completedNCT01660295
What this trial is testing

Pharmacokinetics of Certoparin in Subjects With Renal Insufficiency and Healthy Subjects

Who this might be right for
Renal Insufficiency
Novartis Pharmaceuticals 32
Early research (Phase 1)Study completedNCT05895812
What this trial is testing

A Study in Subjects With Renal Impairment Compared to Subjects With Normal Renal Function

Who this might be right for
Subjects With Renal ImpairmentHealthy Subjects
Shanghai Vinnerna Biosciences Co., Ltd. 24
Early research (Phase 1)Study completedNCT03893799
What this trial is testing

RBT-1 in Healthy Volunteers and Subjects With Stage 3/4 Chronic Kidney Disease

Who this might be right for
Healthy VolunteersChronic Kidney Disease
Renibus Therapeutics, Inc. 54
Early research (Phase 1)UnknownNCT02356419
What this trial is testing

RESP Medication With a Single Intravenous Administration and Dose Escalation to Explore the Tolerability ,Safety and Pharmacokinetic Characteristics

Who this might be right for
Chronic Renal Failure
Shenyang Sunshine Pharmaceutical Co., LTD. 40
Early research (Phase 1)Study completedNCT03318809
What this trial is testing

Study to Evaluate the Safety, Tolerability and Pharmacokinetics of AMG 986 Administered Orally to Healthy Volunteers and Participants With Severely Impaired Renal Function

Who this might be right for
Heart Failure
Amgen 12
Early research (Phase 1)Ended earlyNCT02808052
What this trial is testing

Evaluate Safety and Pharmacokinetics of Minocin (Minocycline) for Injection in Subjects With Renal Insufficiency

Who this might be right for
Renal Insufficiency, AcuteRenal Insufficiency, ChronicHealthy Subjects
Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.) 9
Next Page